BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2026-D0013 A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer clinical trial in vitro diagnostic medical devices CDx multicentric C1 Dr. Anna Dorothea Wagner Incyte Corporation CHUV, Lausanne University Hospital, Lausanne
Inselspital- Universitaetsspital Bern, Bern
HOCH Health Ostschweiz, Kantonsspital St. Gallen
Rorschacher Strasse 95
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Kantonale Ethikkommission Bern, Ethikkommission Ostschweiz (EKOS) 06.05.2026
2026-D0008 Basel Kosten-Effektivitäts-Trial: Drug-coated balloon vs. drug-eluting stent strategy in high-risk patients with coronary artery disease clinical trial medical devices multicentric A1 Prof Gregor Leibundgut B.BRAUN Melsungen AG - Vascular Systems Universitätsspital Basel, Basel
Stadtspital Zürich Triemli, Birmensdorferstrasse 497
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Zürich 20.05.2026
2026-D0005 Diagnostic Protocol for Evaluating the Clinical Performance of VENTANA FOLR1 (FOLR1-2.1) IUO Assay in Determining FOLR1 Status in Tumor Specimens from Platinum-Resistant Ovarian Cancer Patients in Ast More ... clinical trial in vitro diagnostic medical devices CDx multicentric C1 Prof. Dr. Viola Heinzelmann-Schwarz Ventana Medical Systems, Inc. (Roche Tissue Diagnostics [RTD]) Universitätsspital Basel, Basel
Spital STS AG - Spital Thun - Onkologie- und Hamatologiezentrum, Thun
Spital Thurgau-Kantonsspital Muensterlingen, Spitalcampus 1
Kantonsspital St. Gallen, Rorschacher More ...
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern, Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Zürich 27.05.2026
2026-01150 Suppressed Postoperative PTH Predicts Cure in pHPT personal data/biological material multicentric Dr. Ushanthan Uthayanan HOCH Health Ostschweiz HOCH Health Ostschweiz, St. Gallen, St. Gallen
Kantonsspital Winterthur, Winterthur
Ethikkommission Ostschweiz (EKOS) Kantonale Ethikkommission Zürich 04.06.2026
2026-00826 Detecting and Addressing Vaccination Gaps in Children with Chronic Health Conditions personal data/biological material multicentric Ass. Prof. Dr. Dr. sc. med. Nora Fritschi Universität Luzern Universität Luzern, Luzern
Kantonsspital Winterthur - Children’s Hospital Winterthur, Winterthur
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Zürich 06.05.2026
2026-00709 Basal cortisol for clinical routine-based monitoring of adrenal suppression in children after high-dose systemic glucocorticoids: a Swiss two-center study. personal data/biological material multicentric Dr. med. Pascal Gächter Universitäts-Kinderspital beider Basel (UKBB) Universitäts-Kinderspital beider Basel (UKBB), Basel
Kinderspital Kantonsspital Aarau (KSP KSA), Aarau
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Nordwest- und Zentralschweiz EKNZ 18.05.2026
2026-00698 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Parallel Study
to Evaluate the Efficacy and Safety of Enpatoran in Participants with
Active Cutaneous Manifestations of Lupus Erythematosus Wi More ...
clinical trial drugs phase 3 multicentric C Prof.Dr.Dr.med. Antonio COZZIO Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany, Frankfurter Str. 250, 64293 Darmstadt, Germany HOCH Health Ostschweiz, St. Gallen
Universitätsspital Basel, Basel
CHUV - Dermatology, Lausanne
Ethikkommission Ostschweiz (EKOS) Ethikkommission Nordwest- und Zentralschweiz EKNZ, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 11.06.2026
2026-00680 IM027-1016: An Open-label, Multi-center, Long-term Extension Study to Evaluate the Long-term Safety and
Tolerability of Admilparant in Participants with Pulmonary Fibrosis
clinical trial drugs phase 3 multicentric C Prof. Dr. Katrin Hostettler Haack Bristol-Myers Squibb Services Unlimited Company Universitätsspital Basel, Basel
Hopitaux universitaires de Geneve, Geneve
Ethikkommission Nordwest- und Zentralschweiz EKNZ Commission Cantonale d'éthique de la recherche Genève (CCER) 29.05.2026
2026-00671 BODYimage: Investigation of Perfectionism and Gender and their Moderating Role in the Association between Social Media Use and Body dissatisfaction: A Mixed-Methods Study non clinical, involving persons multicentric A Prof. Kerstin von Plessen CHUV - SUPEA - Psychiatrie CHUV, Lausanne
Psychiatrische Universitätklinik Zürich, Zürich
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Kantonale Ethikkommission Zürich 08.06.2026 yes
2026-00593 Predictive risk model for rapid progression under immune checkpoint inhibitor treatment
in patients with recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC) - HNPRO study
personal data/biological material multicentric Dr. med. Eveline Daetwyler HOCH Health Ostschweiz HOCH Health Ostschweiz / Kantonsspital St. Gallen, St. Gallen
Cantonal Hospital Aarau, Aarau
Cantonal Hospital Winterthur, Winterthur
Ethikkommission Ostschweiz (EKOS) Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Zürich 16.04.2026
2026-00518 Orbital Imaging Characteristics in Endogenous Cushing’s Syndrome: A Multicentric Retrospective Observational Study personal data/biological material multicentric Prof. Vincent Dunet Chuv CHUV, Lausanne
HUG, Geneve
HOJG, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD), Commission Cantonale d'éthique de la recherche Genève (CCER) 24.03.2026
2026-00464 MRI-based planning for shoulder arthroplasty non clinical, involving persons multicentric A PD Dr. med. Michael Schär Inselspital, Bern University Hospital, University of Bern Inselspital, Bern University Hospital, Bern
Shoulder, Elbow and Sports Medicine, Sonnenhof Orthopaedics, Bern
Kantonale Ethikkommission Bern Kantonale Ethikkommission Bern 27.05.2026
2026-00461 Vorasidenib as maintenance treatment after first-line chemoradiotherapy in IDH-mutant grade 2 or 3 astrocytoma: a placebo-controlled, triple-blind, randomized phase III study (VIGOR) clinical trial drugs phase 3 multicentric B Dr. Dorothee Gramatzki European Organisation for Research and Treatment of Cancer (EORTC) UniversitaetsSpital Zurich, Zurich
Universitaetsspital Basel, Basel
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ 22.05.2026
2026-00455 A randomized double-masked, multicenter, 3-arm, pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 compared to aflibercept (2 mg) in participants with neo More ... clinical trial drugs phase 2 multicentric C Dr. med. univ. Gábor Márk Somfai Eyebio Limited Triemli Augenklinik Zürich, Zürich
Berner Augenklinik, Bern
Vista Augenklinik Binningen, Binningen
Universitätsspital Basel, Augenklinik, Basel
Hôpital Ophtalmique Jules-Gonin, Lausanne
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 09.06.2026
2026-00454 FAPI PET Imaging - a multicentric exploratory evaluation clinical trial drugs phase 1/2 multicentric C Prof. Dr. med. Martin Hüllner Klinik für Nuklearmedizin, Zürich
Luzerner Kantonsspital, Luzern
Kantonsspital Baden, Baden
Hôpitaux Universitaires Genève, Genève
Clinique de Genolier, Genolier
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD), Commission Cantonale d'éthique de la recherche Genève (CCER) 29.05.2026
2026-00442 Pancreatic resection for localized PDAC in patients with impaired performance status (PANCOG-Study) personal data/biological material multicentric Prof. Dr. Otto Kollmar KSBL Liestal KSBL Liestal, Liestal
Clarunis, University Basel, Basel
Spital Thurgau AG, Frauenfeld
Ente Ospedaliero Cantonale, Lugano
Kantonsspital Winterthur, Winterthur
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Nordwest- und Zentralschweiz EKNZ, Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Zürich, Comitato etico cantonale Ticino 19.03.2026
2026-00431 ROAD – Real-World Outcomes of DArolutamide, ADT, with or without Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer non clinical, involving persons multicentric A PD Dr. med. Aurelius Omlin Bayer Consumer Care AG, Basel, Switzerland Onkozentrum Zürich, Zürich
Zentrum für Urologie und Nephrologie Bern, 3013 Bern
Kantonsspital Fribourg, Fribourg
Kantonsspital Aarau, Aarau
Réseau hospitalier neuchâtelois, 2000 Neuchâtel
HÔPITAL RIVI More ...
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 16.06.2026
2026-00408 Swiss Study on Predicting Food Allergy Resolution (Swiss FARe) non clinical, involving persons multicentric A Professor Caroline Roduit Inselspital Inselspital, Bern
Insel Spital, Bern
Kantonale Ethikkommission Bern Kantonale Ethikkommission Bern 21.04.2026 yes
2026-00371 Correlation and differentiation between dry eye complaints and binocular vision anomalies non clinical, involving persons multicentric A M.Sc. Remo Poffa FHNW Institut für Optometrie FHNW Institut für Optometrie, Olten
Fleury Oticiens S.A., Bulle
Ethikkommission Nordwest- und Zentralschweiz EKNZ Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 10.04.2026
2026-00367 CA266-0002: ROSETTA Lung-202: A Randomized, Double-Blind, Phase 3 Study of PumitamigMonotherapy
Compared to Pembrolizumab as First-line Treatment inParticipants with Locally Advanced or
Metastatic More ...
clinical trial drugs phase 3 multicentric C Prof. Dr. med. Alessandra Curioni-Fontecedro Bristol-Myers Squibb Services Unlimited Company HFR Fribourg - Hôpital Cantonal, Fribourg
Spital STS AG, Onkologie- / Hämatologiezentrum, Thun
CHUV - Centre Hospitalier Universitaire Vaudois Département d'oncologie Clinique, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Kantonale Ethikkommission Bern, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 12.06.2026